Portal Hypertension
235
38
44
87
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
17 trials with published results (7%)
Research Maturity
87 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
10 terminated out of 235 trials
89.7%
+3.1% vs benchmark
15%
36 trials in Phase 3/4
20%
17 of 87 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 87 completed trials
Clinical Trials (235)
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis: an RCT
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
The BD Liverty™ TIPS Stent Graft Study
Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement
Cyanoacrylate Glue Versus Absorbable Gelatin Sponge for Gastric Varices
4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
Austrian PBC Registry
Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
Ultrasound Prediction of Esophageal Variceal Bleeding Risk
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
Early TIPS in Patients With Liver Cirrhosis and Ascites
Freiburg TIPS Registry
Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation
Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement